Precision Medicine in Cardiogenic Shock: We Are Almost There!
- PMID: 37589609
- DOI: 10.1016/j.jchf.2023.06.024
Precision Medicine in Cardiogenic Shock: We Are Almost There!
Keywords: cardiogenic shock; clustering; heterogeneity of treatment effect; phenotyping; precision medicine; predictive enrichment.
Conflict of interest statement
Funding Support and Author Disclosures Dr Mebazaa has received speaker honoraria from Abbott, Orion, Roche, and Servier; and has received fees as a member of the advisory boards and/or steering committees and/or research grants from Bristol Myers Squibb, Adrenomed, Neurotronik, Roche, Sanofi, Sphyngotec, Novartis, Otsuka, Philips and 4TEEN4. Dr Soussi has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Clinical Course of Patients in Cardiogenic Shock Stratified by Phenotype.JACC Heart Fail. 2023 Oct;11(10):1304-1315. doi: 10.1016/j.jchf.2023.05.007. Epub 2023 Jun 21. JACC Heart Fail. 2023. PMID: 37354148
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical